BIOFIRE® SPOTFIRE®
Vaginitis (VG) Panel*
This multiplex PCR test detects eight results associated with vaginitis in around 20 minutes.
*Under FDA review. Seeking CLIA waiver. Subject to change.
Not available for sale in the United States.
Vaginitis affects millions of women every year, yet it is often misdiagnosed because the clinical symptoms of bacterial vaginosis, trichomoniasis, and candidiasis can overlap.1
For more information and to learn why OB/GYNs are turning to molecular testing to fill this diagnostic gap, click below.
Learn MoreBIOFIRE® SPOTFIRE® System
Diagnostic clarity without the wait.
The SPOTFIRE System is a small, scalable, multiplex PCR platform designed to bring fast, accurate, and reliable diagnostic results to the point-of-care (POC) clinical setting. It can be used by any healthcare professional in any healthcare setting.
Learn More
Access information at your fingertips with BIOFIRE® FIREWORKS™.
Available on every SPOTFIRE System, FIREWORKS provides access and insights into all commercially available BIOFIRE and SPOTFIRE Panels. FIREWORKS can improve workflow efficiency via features such as stock management, personalized alerts and notifications, epidemiological trends, and user analytics.
Discover FIREWORKS
References
- Brown H, Drexler M. Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness. Popul Health Manag. 2020 Oct;23(S1):S3-S12. doi: 10.1089/pop.2020.0265. PMID: 32997581